Accuracy Assessment of a Novel Gas Detection Approach in Dyslipidemia Diagnosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: a novel gas detection method for dyslipidemia screening.
- Who it may be relevant to
- Registry conditions: Dyslipidemias, Gas Detection Method. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Accuracy Validation Study of a Novel Gas Detection Method for Dyslipidemia
Overview
This study aims to validate the feasibility and accuracy of a novel gas detection method for dyslipidemia screening by analyzing the lipid profile of human breath metabolites. It explores a simple, rapid, and non-invasive method for screening dyslipidemia. The application prospects of this method are broad; it can be used not only for early screening and monitoring of dyslipidemia in hospitals and communities, providing strong support for the prevention of cardiovascular diseases, but also for the routine monitoring and treatment effectiveness evaluation of patients with hyperlipidemia, offering a scientific basis for personalized treatment plans. This study not only has profound scientific value but also provides a theoretical basis for the development of subsequent new clinical testing methods.
Interventions
- Diagnostic test a novel gas detection method for dyslipidemia screening
Multidimensional Mass Spectrometry Technologies Based on Exhaled Metabolic Fingerprint Spectra for Dyslipidemia Detection
Primary outcome measures
- accuracy of cholesterol testing [Time frame: within 1 week day of sample collection]
Eligibility criteria
Inclusion criteria
- Age ≥ 18 years
- Voluntarily signed the informed consent form
Exclusion criteria
- Patients with lung cancer, asthma, chronic obstructive pulmonary disease, pulmonary cystic fibrosis, or acute respiratory distress syndrome
- Women who are pregnant or breastfeeding
- Patients with chronic kidney disease (GFR < 60 ml/min) or cirrhosis
- Individuals unable to cooperate with the collection of exhaled gas samples
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Ecologic or community
Study locations
China · 1 center
- Beijing Anzhen hospital — Beijing
Identifiers
NCT: NCT06486857 · KS2024055